Physician profile
Reetu Singh
NPI 1275534737
$9,405.47
in general payments reported to CMS, 2019-2025
63 companies · $2,475 in 2025
The $2,475 reported for 2025 was more than what 80% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,527 · 2020: $284 · 2021: $414 · 2022: $1,185 · 2023: $1,652 · 2024: $1,869 · 2025: $2,475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,923 · Education: $73.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,922.67 |
| Education | $73.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,041.89 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $1,016.61 | 2019-2025 | Evenity, Prolia, Repatha |
| Novo Nordisk INC | $975.52 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $758.37 | 2019-2025 | Jardiance, Ofev, Synjardy |
| Corcept Therapeutics | $435.13 | 2019-2025 | Korlym |
| Abbott Laboratories | $334.23 | 2019-2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $284.60 | 2019-2025 | |
| Insulet Corporation | $251.23 | 2022-2024 | Omnipod |
| Amneal Pharmaceuticals LLC | $241.38 | 2023-2025 | Unithroid |
| Harmony Biosciences LLC | $232.36 | 2023-2025 | Wakix |
| Sanofi-Aventis U.S. LLC | $229.24 | 2019-2025 | |
| Dexcom, INC. | $215.78 | 2021-2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals Lp | $190.03 | 2019-2024 | Fasenra, Farxiga |
| Radius Health, INC. | $179.41 | 2021-2025 | Tymlos |
| Tandem Diabetes Care, INC. | $178.56 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $176.04 | 2024-2025 | Xolair |
| Actelion Pharmaceuticals US, INC. | $162.17 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Mallinckrodt Hospital Products INC. | $161.01 | 2020-2024 | Acthar |
| Xeris Pharmaceuticals, INC. | $129.61 | 2022-2025 | Recorlev, Gvoke Hypopen |
| Medtronic, INC. | $121.57 | 2023-2025 | Minimed 780g |
| Novartis Pharmaceuticals Corporation | $120.80 | 2023-2025 | |
| Abbvie INC. | $119.93 | 2019-2025 | |
| Ani Pharmaceuticals, INC. | $115.02 | 2024-2025 | Purified Cortrophin Gel |
| Verona Pharma, INC. | $111.20 | 2025 | Ohtuvayre |
| United Therapeutics Corporation | $105.58 | 2023-2024 | Tyvaso |
| Sunovion Pharmaceuticals INC. | $98.07 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $97.02 | 2023-2025 | Glassia |
| Esperion Therapeutics, INC. | $84.01 | 2021-2025 | Nexletol |
| Jazz Pharmaceuticals INC. | $83.74 | 2023-2024 | |
| Beta Bionics, INC. | $82.91 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Grifols USA, LLC | $69.56 | 2024-2025 | Prolastin-C Liquid |
| Amarin Pharma, INC. | $60.38 | 2019-2022 | |
| Shire North American Group INC | $59.48 | 2019 | |
| Lifescan, INC. | $54.37 | 2020-2022 | |
| Horizon Therapeutics Plc | $53.24 | 2022-2023 | Tepezza |
| Madrigal Pharmaceuticals | $52.86 | 2024-2025 | Rezdiffra, Resmetirom |
| Recordati_rare_diseases_inc. | $43.68 | 2024 | Isturisa, Signifor Lar |
| Axsome Therapeutics, INC. | $43.41 | 2023 | Sunosi |
| Tactile Systems Technology INC | $43.20 | 2025 | Flexitouch Plus, Nimbl |
| Avadel Cns Pharmaceuticals, LLC | $43.16 | 2024 | Lumryz |
| Chiesi USA, INC. | $42.28 | 2024-2025 | Myalept |
| Sequel Med Tech, LLC | $37.14 | 2025 | Twiist |
| Cequr Corporation | $34.11 | 2023-2024 | Cequr Simplicity |
| Mallinckrodt Enterprises LLC | $33.10 | 2019 | |
| Electromed, INC. | $32.27 | 2024-2025 | Smartvest |
| Philips North America LLC | $32.04 | 2025 | Vest Therapy Und, Patient Interface Software |
| Alexion Pharmaceuticals, INC. | $30.92 | 2023-2024 | Strensiq |
| Becton, Dickinson and Company | $28.54 | 2019 | |
| Janssen Pharmaceuticals, INC | $27.81 | 2019 | |
| Averitas Pharma INC. | $27.46 | 2023 | Qutenza |
| Rhythm Pharmaceuticals, INC. | $24.63 | 2025 | Imcivree |
| Ultragenyx Pharmaceutical INC. | $24.25 | 2024 | Crysvita |
| Pfizer INC. | $20.42 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $18.51 | 2019 | |
| Circassia INC. | $18.44 | 2019 | |
| Resmed Corp | $17.87 | 2024 | |
| Glaxosmithkline, LLC. | $16.17 | 2019 | |
| Baxter Healthcare | $15.95 | 2023 | Hillrom - Volara System |
| Mylan Specialty L.P. | $15.36 | 2021 | |
| Eisai INC. | $14.78 | 2021 | |
| Merck Sharp & Dohme LLC | $12.65 | 2021 | |
| Medtronic Minimed, INC. | $12.22 | 2019 | |
| Gilead Sciences, INC. | $12.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reetu Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.